These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 1989859)

  • 1. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I; Gottschall PE; Arimura A
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE; Tatsuno I; Miyata A; Arimura A
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions.
    Shivers BD; Görcs TJ; Gottschall PE; Arimura A
    Endocrinology; 1991 Jun; 128(6):3055-65. PubMed ID: 2036976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D; Delgado M; Martinez C; Gomariz RP; Guerrero JM; Calvo JR
    Biochim Biophys Acta; 1997 Dec; 1359(3):250-62. PubMed ID: 9434131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: molecular identification and interaction with vasoactive intestinal peptide (VIP).
    Tatsuno I; Gottschall PE; Arimura A
    Peptides; 1991; 12(3):617-21. PubMed ID: 1923939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes.
    Tatsuno I; Gottschall PE; Köves K; Arimura A
    Biochem Biophys Res Commun; 1990 May; 168(3):1027-33. PubMed ID: 2346475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
    Bodart V; Babinski K; Ong H; De Léan A
    Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification.
    Gottschall PE; Tatsuno I; Arimura A
    FASEB J; 1991 Feb; 5(2):194-9. PubMed ID: 1848519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K; Smith DM; Ghatei MA; Murphy JK; Bloom SR
    J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide regulation of AtT-20/D16v corticotrope cell proopiomelanocortin expression and secretion.
    Braas KM; Brandenburg CA; May V
    Endocrinology; 1994 Jan; 134(1):186-95. PubMed ID: 8275932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 67 kDa protein mediates pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated insulin secretion in a hamster clonal beta-cell line.
    Kulkarni RN; Smith DM; Ghatei MA; Bloom SR
    J Endocrinol; 1995 Oct; 147(1):121-30. PubMed ID: 7490525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP.
    Delgado M; De la Fuente M; Martínez C; Gomariz RP
    J Neuroimmunol; 1995 Nov; 62(2):137-46. PubMed ID: 7499501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.